首页> 美国卫生研究院文献>Oncotarget >A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis
【2h】

A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis

机译:中国家族性腺瘤性息肉病家庭APC基因第14内含子中的一种新型致病性剪接受体位点种系突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Familial adenomatous polyposis (FAP) is an autosomal dominant precancerous condition, clinically characterized by the presence of multiple colorectal adenomas or polyps. Patients with FAP has a high risk of developing colorectal cancer (CRC) from these colorectal adenomatous polyps by the mean age of diagnosis at 40 years. Germline mutations of the APC gene cause familial adenomatous polyposis (FAP). Colectomy has recommended for the FAP patients with significant polyposis. Here, we present a clinical molecular study of a four generation Chinese family with FAP. Clinical diagnosis of FAP has been done according to the phenotype, family history and medical records. Patient's blood samples were collected and genomic DNA was extracted. In order to identify the pathogenic mutation underlying the disease phenotype targeted next-generation sequencing and confirmatory sanger sequencing has undertaken. Targeted next generation sequencing identified a novel heterozygous splice-acceptor site mutation [c.1744-1G>A] in intron 14 of APC gene, which is co-segregated with the FAP phenotypes in the proband and amongst all the affected family members. This mutation is not present in unaffected family members and in normal healthy controls of same ethnic origin. According to the LOVD database for Chinese colorectal cancer patients, in Chinese population, 60% of the previously reported APC gene mutations causes FAP, are missense mutations. This novel splice-acceptor site mutation causing FAP in this Chinese family expands the germline mutation spectrum of the APC gene in the Chinese population.
机译:家族性腺瘤性息肉病(FAP)是常染色体显性癌前状态,临床特征是存在多个结直肠腺瘤或息肉。患有FAP的患者在40岁的平均诊断年龄时有从这些大肠腺瘤性息肉发展为大肠癌(CRC)的风险。 APC基因的种系突变导致家族性腺瘤性息肉病(FAP)。结肠切除术已建议患有严重息肉病的FAP患者。在这里,我们介绍了具有FAP的四代中国家庭的临床分子研究。已根据表型,家族史和病历对FAP进行了临床诊断。收集患者的血样并提取基因组DNA。为了鉴定疾病表型的致病突变,已经进行了靶向下一代测序和证实性桑格测序。有针对性的下一代测序在APC基因内含子14中鉴定了一个新的杂合剪接受体位点突变[c.1744-1G> A],该突变与先证者中的FAP表型以及所有受影响的家庭成员中共同分离。在未受影响的家庭成员和具有相同种族血统的正常健康对照中不存在此突变。根据针对中国结直肠癌患者的LOVD数据库,在中国人群中,先前报道的APC基因突变中有60%导致FAP,是错义突变。这种在中国家庭中引起FAP的新的剪接受体位点突变扩大了中国人群中APC基因的种系突变谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号